Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 6/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25598596 | 0.90 | CXCR2 (0.46) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL25602752 | 0.90 | CXCR2 (0.46) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL23460939 | 0.83 | CXCR2 (0.46) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL23460936 | 0.83 | CXCR2 (0.46) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL25599446 | 0.83 | CXCR2 (0.43) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL23459942 | 0.83 | CXCR2 (0.43) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL25598661 | 0.83 | CXCR2 (0.43) | CXCR2PTPN2PTPN1PTPN7 | |
| SCHEMBL23460976 | 0.82 | CXCR2 (0.49) | CXCR2 | |
| SCHEMBL25548759 | 0.82 | CXCR2 (0.49) | CXCR2 | |
| SCHEMBL25598610 | 0.81 | CXCR2 (0.42) | CXCR2PTPN2PTPN1PTPN7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159439-A1 | ARYLAMIDES AND METHODS OF USE THEREOF | GENZYME CORPORATION | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159439-A1 | ARYLAMIDES AND METHODS OF USE THEREOF | CFTR, AADAC, ARSA | CXCR2 1205/4885PTPN2 1439/4885PTPN1 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.